Providing solutions to the manufacturing challenges of gene and cell therapy has never been so important. Successes in gene therapy are taking center stage and we are seeing a new dawn in terms of commercialization. Pricing and reimbursement often take the headlines, but the challenges of manufacturing are equally important. Processes must be robust, scalable, and meet regulatory requirements.
This webinar explores plasmid DNA and other critical materials and components for gene and cell therapy manufacturing including specifications, regulatory considerations, timelines and supply agreements.
The discussion includes:
Hear from our panel of experts: